X
  • What New Strategies are Accelerating the Growth of the Medical Food Landscape?
    Collaborative efforts between drug manufacturers and medical food manufacturers to boost growth opportunities for medical food

    Research Overview

    The US FDA defines medical food as “a food, which is formulated to be consumed or administered enterally under the supervision of a physician and which is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation.“ Medical food is interpreted as 'food for special medical purposes (FSMPs)' in several countries, including Europe, India, China, and Australia and New Zealand. In Japan, medical food is interpreted as 'food for sick'. In Canada, medical food is governed by food for special dietary use (FSDU) and infant food regulations.

    Globally, the regulatory landscape for medical food is not clearly defined, even in developed economies. As medical food is not intended to prevent or treat diseases, it is not subject to the same regulatory requirements as pharmaceutical drugs.

    This Frost & Sullivan study aims to understand the role of medical food in patients' recovery. It provides qualitative and quantitative analyses of medical food ingredients and finished product medical food.

  • GROWTH PIPELINE DIALOG™

    Take your first step towards achieving growth-centric solutions with our Growth Pipeline Dialog™. Speak to our industry experts in a complimentary open discussion that will spark innovative thinking and growth opportunities that will benefit your organization.

    HAVE A SUBSCRIPTION?
    Access Research Via